How Is The Kernicterus Treatment Market Expected To Grow At 2.1% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Kernicterus Treatment Market Be Worth By 2029?
The market size for treatment of kernicterus has seen a slight increase in recent years, escalating from $2.98 billion in 2024 to $3.03 billion in 2025, recording a compound annual growth rate (CAGR) of 2.0%. The growth during the historical period can be credited to advancements in the care for newborns, enhanced knowledge amongst medical experts, government-led initiatives in the field of mother and child health, investment in research and clinical trials, as well as collaborations in medical research.
In the coming years, the market size for the treatment of kernicterus is anticipated to grow steadily, reaching a valuation of $3.3 billion in 2029 with a compound annual growth rate of 2.1%. This projected growth in the forecast period can be ascribed to continuous educational programs in the medical field, global health policy enactments and initiatives, patient advocacy and assistance groups, the collaboration of research at an international level in pediatrics, and government sponsorship for neonatal health. Upcoming trends in the forecast period comprise advances in monitoring technologies for neonatal jaundice, the launch of phototherapy devices with superior features, the advent of medications that reduce bilirubin, emphasis on solutions for phototherapy at home, the application of guidelines and nomograms for bilirubin, and the incorporation of telehealth for monitoring from remote locations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp
What External And Internal Drivers Are Influencing The Kernicterus Treatment Market?
Neonatal jaundice’s high occurrence rate contributes heavily to the expansion of the market for treating kernicterus. Colloquially referred to as newborn jaundice, this widespread but usually harmless condition manifests yellow hues in a baby’s skin and eye whites. The standard treatment for neonatal jaundice is kernicterus treatment; it provides relief from symptoms and supportive care. The treatment involves the extraction of blood from the infant, which is then replaced with blood manifesting lower bilirubin levels—augmenting the affected child’s life quality. For example, data from the US-based National Library of Medicine disclosed that in October 2023, roughly 60% of term babies and 80% of premature babies faced jaundice within the first week itself. Additionally, about 10% of breastfed babies continue to be jaundiced even after a month. Thus, the widespread occurrence of neonatal jaundice is anticipated to significantly boost the kernicterus treatment market’s progression.
What Segmentation Insights Are Provided In The Kernicterus Treatment Market Research?
The kernicterus treatmentmarket covered in this report is segmented –
1) By Treatment: Phototherapy; Intravenous Immunoglobulins (IVIG); Blood Transfusion; Medication; Other Treatments
2) By Symptoms: Jaundice; Unusual Eye Movements; Vomiting; Fever; Poor Feeding; Apnoea; Irritability; Seizures; Sleepiness; Other Symptoms
3) By Dosage: Injection; Solution; Other Dosages
4) By End-Users: Clinic; Hospital; Other End-Users
Subsegments:
1) By Phototherapy: Conventional Phototherapy; Fiberoptic Phototherapy; LED Phototherapy
2) By Intravenous Immunoglobulins (IVIG): Standard IVIG Therapy; High-Dose IVIG Therapy
3) By Blood Transfusion: Exchange Transfusion; Simple Transfusion
4) By Medication: Bilirubin-Lowering Agents; Antioxidants; Neuroprotective Agents
5) By Other Treatments: Supportive Care; Nutritional Support; Adjunct Therapies
Which Notable Trends Are Transforming The Kernicterus Treatment Market Outlook?
The primary players in the cornea treatment market are shifting their strategies to focus more on partnerships in order to extend their reach and strengthen their market position. An example of this includes the UCL Department of Medical Physics and Biomedical Engineering, an institution based in the UK, that in July 2024, not only contributed to research and education in medical physics and biomedical engineering, but also formed a partnership with UK-based UCL Hospitals to launch NeoSCB. This innovative smartphone application helps to diagnose severe jaundice in newborns by analysing images of the sclera (the white part of the eye), acting as a non-invasive method of screening. This is crucial in areas where resources are lacking and traditional jaundice screening devices are unaffordable. The app determines the severity of jaundice by measuring the degree of yellowness in the sclera and comparing this with bilirubin levels in the bloodstream. Out of 79 severely jaundiced infants, the app managed to accurately identify 74, exhibiting a higher efficacy rate, comparable to conventional methods like transcutaneous bilirubinometers that evaluate bilirubin through the skin.
Who Are The Leading Companies Driving The Kernicterus Treatment Market?
Major companies operating in the kernicterus treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Johnson and Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Alembic Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited, Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd., Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd., Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., China Biologic Products Holdings Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Kernicterus Treatment Market?
North America was the largest region in the kernicterus treatment market in 2024. The regions covered in the kernicterus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13470&type=smp
Browse Through More Reports Similar to the Global Kernicterus Treatment Market 2025, By The Business Research Company
Neurofibromatosis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
Optic Nerve Disorders Treatment Global Market Report 2025
Zollinger Ellison Syndrome Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
